Longevity Weekly Review 2026-07-08
Week In Review Longevity science this week continued its measurable pivot from “will it work in mice?” to “what exactly is it doing in humans, and can we prove it with the tools we have?” The clearest signal came from Retro Biosciences, whose CEO Joe Betts-LaCroix reported that the company’